- ►annals.org [PDF] A Fritsche, MA Schweitzer, HU Haring… - Annals of internal medicine, 2003 - Am Coll Physicians Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral ...
Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients ... Andreas
Fritsche, MD; Matthias Axel Schweitzer, MD; Hans-Ulrich Häring, MD; and ... Cited by 158 - Related articles - BL Direct - All 7 versions
M Massi Benedetti, E Humburg, A Dressler, … - Hormone and metabolic research, 2003 - cat.inist.fr Aims: The aim of the trial was to compare the efficacy and safety of the new,
long-acting basal insulin, insulin glargine(LANTUS®), with NPH human
insulin, each administered in a combination regimen with oral antidiabetic ... Cited by 103 - Related articles - BL Direct - All 2 versions
MC Riddle, J Rosenstock, J Gerich - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a randomized, open-label, parallel, 24-week
multicenter trial, 756 overweight men and women with inadequate glycemic control
(HbA 1c >7.5%) on one or two oral agents continued prestudy oral agents and ... Cited by 424 - Related articles - BL Direct - All 6 versions
- Free from Publisher J Rosenstock, SL Schwartz, CM Clark Jr, GD … - Diabetes Care, 2001 - 万方数据资源系统 OBJECTIVE: To determine the safety and efficacy of the long-acting analog
insulin glargine compared with NPH insulin in patients with type 2 diabetes who
were previously treated with insulin alone. RESEARCH DESIGN AND METHODS: A ... Cited by 345 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] H Yki-Jarvinen, A Dressler, M Ziemen - Diabetes Care, 2000 - Am Diabetes Assoc (3,2), sulfonylureas and metformin (1,3,5), or metformin alone (3) gives as good
overall glycemic control than the use of several insulin injections (1,3,4,6,7).
However, use of NPH insulin creates 2 problems. If NPH insulin is injected ... Cited by 155 - Related articles - All 5 versions
H Yki-Jarvinen, A Dressler, M Ziemen… - Diabetes Care, 2000 - Am Diabetes Assoc (3,2), sulfonylureas and metformin (1,3,5), or metformin alone (3) gives as good
overall glycemic control than the use of several insulin injections (1,3,4,6,7).
However, use of NPH insulin creates 2 problems. If NPH insulin is injected ... Cited by 143 - Related articles - BL Direct - All 3 versions
- Free from Publisher A Wright, AC Burden, RB Paisey, CA CULI, … - Diabetes Care, 2002 - cat.inist.fr OBJECTIVE- To evaluate the efficacy of the addition of insulin when maximal
sulfonylurea therapy is inadequate in individuals with type 2 diabetes. RESEARCH
DESIGN AND METHODS- Glycemic control, hypoglycemia, and body weight were ... Cited by 222 - Related articles - BL Direct - All 5 versions
HU Janka, G Plewe, MC Riddle, C Kliebe- … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a 24-week, multinational, multicenter, open,
parallel group clinical trial, 371 insulin-naïve patients with poor glycemic
control (fasting blood glucose [FBG] ≥120 mg/dl, HbA 1c 7.5–10.5%) on ... Cited by 222 - Related articles - All 8 versions
H Yki-Järvinen, R Kauppinen-Mäkelin, M … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 442–451 DOI 10.1007/s00125-005-0132-0 ARTICLE H.
Yki-Järvinen . R. Kauppinen-Mäkelin . M. Tiikkainen . M. Vähätalo . ... Cited by 156 - Related articles - BL Direct - All 7 versions
J Rosenstock, G Dailey, M Massi-Benedetti, A … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—Insulin glargine (LANTUS) is a once-daily basal insulin analog with
a smooth 24-h time-action profile that provides effective glycemic control with
reduced hypoglycemia risk (particularly nocturnal) compared with NPH ... Cited by 196 - Related articles - All 6 versions
